| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
May 28, 2019
DUBLIN - May 28, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced real-world clinical outcomes for the MiniMed(TM) 670G system, which is being used by more...
-
May 24, 2019
DUBLIN - May 24, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced that it will participate in the Bernstein 35th Annual Strategic Decisions Conference on...
-
May 23, 2019Q4 Revenue of $8.1 Billion, Flat as Reported and Grew 3.6% Organic
DUBLIN - May 23, 2019 - Medtronic plc (NYSE:MDT) today announced financial results for its fiscal year and fourth quarter 2019, which ended April 26, 2019. Medtronic's fiscal year 2019 revenue of...
-
May 11, 2019Company to Proceed with Plans for Future Pivotal Study of New ICD System
DUBLIN and SAN FRANCISCO – May 11, 2019 – Medtronic plc (NYSE:MDT) today announced findings from a pilot study of its investigational Extravascular Implantable Cardioverter Defibrillator (EV...
-
May 10, 2019Treatment Disparities Prevent Indicated Patients from Receiving Evidence-Recommended Life-Saving Devices
DUBLIN and SAN FRANCISCO - May 10, 2019 - Three new studies show that patients who are medically indicated for implantable heart devices, including implantable cardioverter defibrillators (ICDs)...
-
May 7, 2019To Assess the Potential of Non-Opioid Treatment Options for Chronic Pain, Study Evaluates Pain Relief, Patient Function and Satisfaction
DUBLIN and LAS VEGAS - May 7, 2019 - Medtronic plc (NYSE:MDT) today announced primary endpoint (3-month) results of the Vectors Post Market Clinical Study that demonstrated effective pain relief...
-
Apr 30, 2019System Offers New Options for Improving Outcomes in Treating Stroke; World's Second-Leading Cause of Death, Third-Leading Cause of Disability
DUBLIN - April 30, 2019 - Medtronic plc (NYSE:MDT) today announced the U.S. launch of the Solitaire(TM) X Revascularization Device - and its first use in patients for the treatment of acute...
-
Mar 17, 2019Late-Breaking Trial Results Presented at ACC Scientific Sessions and Published in The New England Journal of Medicine
DUBLIN and NEW ORLEANS - March 17, 2019 - Medtronic plc (NYSE:MDT) today announced results from the landmark Worldwide Randomized Antibiotic Envelope Infection Prevention Trial (WRAP-IT), which...
-
Mar 16, 2019Less Invasive Evolut™ Transcatheter Aortic Valve Replacement (TAVR) System Successful in Clinical Trial When Compared to Open Heart Surgery in Healthier Aortic Stenosis Patients
DUBLIN and NEW ORLEANS – March 16, 2019 – Medtronic plc (NYSE:MDT) today announced first-ever clinical data from the landmark Evolut Low Risk Trial comparing the minimally invasive Evolut™...
-
Mar 8, 2019Board Authorizes $6 Billion for Share Repurchases
DUBLIN - March 8, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 fourth quarter cash dividend of $0.50 per ordinary share, representing a 9 percent...
-
Mar 7, 2019
DUBLIN - March 7, 2019 - Medtronic plc (the "Company") (NYSE:MDT) today announced that its wholly-owned subsidiary Medtronic Global Holdings S.C.A. ("Medtronic Luxco") has closed a registered...
-
Mar 6, 2019
DUBLIN - March 6, 2019 - Medtronic plc (the "Company") (NYSE:MDT) today announced the pricing terms of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc....
-
Mar 6, 2019
DUBLIN - March 6, 2019 - Medtronic plc (the "Company") (NYSE:MDT) today announced that, pursuant to the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc....
-
Mar 4, 2019
DUBLIN - March 4, 2019 - Medtronic plc (NYSE:MDT) announced today that its wholly-owned subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), has priced an offering of €500,000,000...
-
Mar 4, 2019
DUBLIN - March 4, 2019 - Medtronic plc (the "Company") (NYSE:MDT) today announced the upsizing of the previously-announced cash tender offers by its wholly-owned subsidiaries, Medtronic, Inc. and...
-
Mar 1, 2019
DUBLIN - March 1, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 39th Annual Cowen and Company Healthcare Conference on...
-
Feb 27, 2019Medtronic Expands Pain Portfolio with Minimally Invasive Therapy to Support Patients Throughout the Care Continuum
DUBLIN - February 27, 2019 - Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Accurian(TM) RF ablation platform, which conducts radio...
-
Feb 20, 2019
DUBLIN - February 20, 2019 - Medtronic plc (the "Company") (NYSE: MDT) today announced the commencement of a cash tender offer by its indirectly wholly owned subsidiaries, Medtronic, Inc....
-
Feb 20, 2019Medtronic EVP & RTG President Geoff Martha to Speak at Leerink Partners Global Healthcare Conference
DUBLIN - February 20, 2019 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 8th Annual Leerink Partners Global Healthcare Conference...
-
Feb 14, 2019Value-Based Health Care Partnership Will Target Acute Conditions and Chronic Diseases in South Carolina
DUBLIN and CHARLESTON, S.C. - February 14, 2019 - Medtronic plc (NYSE:MDT) and the Medical University of South Carolina (MUSC) today announced a five-year value-based health care partnership...
-
Jan 30, 2019New RESCUE Trial Data Presented in Blunt Thoracic Aortic Injury
DUBLIN and SAN DIEGO - January 30, 2019 - Medtronic plc (NYSE:MDT) today announced new data supporting the long-term durability, safety, and efficacy of the Valiant(TM) Captivia(TM) thoracic stent...
-
Jan 17, 2019Study Will Further Advance Understanding of Effectiveness and Tolerability of the SynchroMed(TM) II Intrathecal Drug Delivery System in Patients Who Have Weaned off Oral Opioids
DUBLIN - January 17, 2019 - Medtronic plc (NYSE:MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the...
-
Dec 28, 2018
DUBLIN - December 28, 2018 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the 37th Annual J.P. Morgan Healthcare Conference in San...
-
Dec 7, 2018
DUBLIN - December 7, 2018 - The board of directors of Medtronic plc (NYSE:MDT) today approved the fiscal year 2019 third quarter cash dividend of $0.50 per ordinary share, representing a 9 percent...
-
Dec 3, 2018Study Will Evaluate Simultaneous Use of Radiofrequency and Cryo Surgical Ablation Devices in Cardiac Surgery Patients with Atrial Fibrillation
DUBLIN - December 3, 2018 - Medtronic plc (NYSE:MDT) today announced the first patient treated in the TERMINATE AF trial, a multi-center study evaluating two surgical ablation devices - the...